Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Shares Outstanding (Diluted Average): 2020-2024

Historic Shares Outstanding (Diluted Average) for Prime Medicine (PRME) over the last 5 years, with Dec 2024 value amounting to $118.6 million.

  • Prime Medicine's Shares Outstanding (Diluted Average) rose 34.02% to $160.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.5 million, marking a year-over-year increase of 34.02%. This contributed to the annual value of $118.6 million for FY2024, which is 30.37% up from last year.
  • As of FY2024, Prime Medicine's Shares Outstanding (Diluted Average) stood at $118.6 million, which was up 30.37% from $91.0 million recorded in FY2023.
  • Prime Medicine's 5-year Shares Outstanding (Diluted Average) high stood at $118.6 million for FY2024, and its period low was $2.6 million during FY2020.
  • For the 3-year period, Prime Medicine's Shares Outstanding (Diluted Average) averaged around $81.2 million, with its median value being $91.0 million (2023).
  • Data for Prime Medicine's Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 391.47% (in 2021) over the last 5 years.
  • Prime Medicine's Shares Outstanding (Diluted Average) (Yearly) stood at $2.6 million in 2020, then skyrocketed by 391.47% to $13.0 million in 2021, then soared by 161.23% to $33.9 million in 2022, then soared by 168.42% to $91.0 million in 2023, then skyrocketed by 30.37% to $118.6 million in 2024.